{"id":28488,"date":"2026-10-23T14:00:18","date_gmt":"2026-10-23T07:00:18","guid":{"rendered":"https:\/\/www.nanovest.io/blog\/?p=28488"},"modified":"2026-10-23T14:00:18","modified_gmt":"2026-10-23T07:00:18","slug":"data-vaksin-kanker-bocor-moderna-turun","status":"publish","type":"post","link":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/","title":{"rendered":"Data Vaksin Kanker Bocor, Saham Moderna Turun"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Saham <\/span><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=MRNA&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DMRNA\"><b>Moderna (MRNA)<\/b><\/a><span style=\"font-weight: 400;\"> mengalami tekanan tajam pada perdagangan Kamis, 22 Oktober 2026, setelah hasil uji klinis tahap akhir vaksin kanker melanoma yang dikembangkan bersama <\/span><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=MRK&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DMRK\"><b>Merck (MRK)<\/b><\/a><span style=\"font-weight: 400;\"> beredar lebih awal dari jadwal.<\/span><span style=\"font-weight: 400;\"> Saham Moderna sempat anjlok lebih dari 25% sebelum memangkas kerugian dan ditutup turun 17,57%.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Penurunan tersebut terjadi meskipun data penelitian menunjukkan hasil positif. Kondisi ini menjadi sorotan karena saham Moderna sebelumnya telah mencatat reli besar, didorong optimisme investor terhadap pengembangan vaksin kanker berbasis mRNA.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_89 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Daftar Isi <\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#Data_Vaksin_Kanker_Bocor_Saham_Moderna_Tertekan\" >Data Vaksin Kanker Bocor, Saham Moderna Tertekan<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#Hasil_Uji_Klinis_Risiko_Kekambuhan_Turun_42\" >Hasil Uji Klinis: Risiko Kekambuhan Turun 42%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#Mengapa_Saham_Moderna_Anjlok_Meski_Hasilnya_Positif\" >Mengapa Saham Moderna Anjlok Meski Hasilnya Positif?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#Investor_Menanti_Data_Lengkap_di_Konferensi_ESMO\" >Investor Menanti Data Lengkap di Konferensi ESMO<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Data_Vaksin_Kanker_Bocor_Saham_Moderna_Tertekan\"><\/span><b>Data Vaksin Kanker Bocor, Saham Moderna Tertekan<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Hasil uji klinis Fase 3 vaksin melanoma personalisasi Moderna, yang dikenal sebagai <\/span><i><span style=\"font-weight: 400;\">intismeran<\/span><\/i><span style=\"font-weight: 400;\">, dilaporkan sempat muncul di situs OncologyCentral sebelum pengumuman resmi perusahaan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Data tersebut awalnya dijadwalkan untuk dipresentasikan pada Sabtu, 24 Oktober 2026, dalam kongres European Society for Medical Oncology (ESMO) di Madrid, Spanyol.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Setelah informasi beredar, Moderna dan Merck merilis hasil penelitian lebih awal. Reaksi pasar berlangsung cepat, dengan saham Moderna sempat turun hingga sekitar 26% dalam perdagangan intraday dan menjadi saham dengan penurunan terbesar di indeks S&amp;P 500 pada hari tersebut.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Menurut laporan Reuters saat perdagangan masih berlangsung, aksi jual sempat menghapus sekitar US$24 miliar dari kapitalisasi pasar Moderna. Saham kemudian memangkas sebagian penurunannya hingga penutupan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Saham <\/span><a href=\"https:\/\/nanovest.go.link\/page=IndividualStockDetail?action=navigate&amp;is_param=true&amp;symbol=MRK&amp;adj_t=1rhus2a1&amp;adj_deep_link=nanovest%3A%2F%2Fpage%3DIndividualStockDetail%3Faction%3Dnavigate%26is_param%3Dtrue%26symbol%3DMRK\"><b>Merck (MRK)<\/b><\/a><span style=\"font-weight: 400;\"> juga melemah, tetapi penurunannya lebih terbatas.<\/span><span style=\"font-weight: 400;\"> Pada penutupan perdagangan, saham MRK turun sekitar 1,76%.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Perbedaan reaksi tersebut mencerminkan besarnya perhatian investor terhadap vaksin melanoma dalam prospek bisnis Moderna, sementara Merck memiliki portofolio produk yang lebih luas.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Hasil_Uji_Klinis_Risiko_Kekambuhan_Turun_42\"><\/span><b>Hasil Uji Klinis: Risiko Kekambuhan Turun 42%<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Penelitian Fase 3 melibatkan lebih dari 1.100 pasien melanoma berisiko tinggi dan mengevaluasi penggunaan intismeran bersama obat imunoterapi Keytruda milik Merck.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hasilnya menunjukkan bahwa kombinasi kedua terapi tersebut mampu mengurangi risiko kekambuhan kanker atau kematian sebesar 42% dibandingkan penggunaan Keytruda saja. Selain itu, terapi tersebut juga mengurangi risiko metastasis jauh atau kematian sebesar 38% dibandingkan Keytruda saja.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Metastasis jauh merujuk pada penyebaran kanker ke bagian tubuh lain yang jauh dari lokasi awal penyakit.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Hasil penelitian sebelumnya pada kelompok pasien yang lebih kecil menunjukkan penurunan risiko kekambuhan atau kematian sebesar 49%. Namun, kedua angka tersebut tidak dapat dibandingkan secara langsung karena melibatkan populasi pasien yang berbeda.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Moderna dan Merck juga menyampaikan bahwa data <\/span><i><span style=\"font-weight: 400;\">overall survival<\/span><\/i><span style=\"font-weight: 400;\"> atau kelangsungan hidup secara keseluruhan belum lengkap, meskipun hasil sementara menunjukkan tren yang menguntungkan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kedua perusahaan tengah berinteraksi dengan otoritas regulasi terkait pengembangan terapi tersebut. Data yang akan dipresentasikan pada konferensi ESMO menjadi perhatian berikutnya, termasuk rincian hasil pada kelompok pasien dengan tingkat risiko berbeda.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mengapa_Saham_Moderna_Anjlok_Meski_Hasilnya_Positif\"><\/span><b>Mengapa Saham Moderna Anjlok Meski Hasilnya Positif?<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Penurunan saham Moderna terjadi setelah kenaikan harga yang sangat besar dalam beberapa bulan terakhir.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pada 19 Agustus 2026, saham MRNA melonjak 177% dalam sehari dan ditutup pada US$174,38 setelah Moderna dan Merck mengumumkan bahwa uji klinis melanoma telah mencapai tujuan utamanya.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Reli berlanjut hingga saham Moderna mencatatkan harga penutupan tertinggi sejak Desember 2021 pada Rabu, 21 Oktober. Sebelum aksi jual terbaru, sahamnya telah meningkat hampir empat kali lipat sejak pertengahan Agustus.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Menurut laporan Investopedia, meskipun mengalami penurunan tajam, saham Moderna masih mencatat kenaikan hampir 600% sejak awal tahun.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Analis UBS, William Blair, dan TD Cowen menilai hasil uji klinis tersebut tetap kuat. Namun, ekspektasi pasar telah meningkat signifikan setelah reli saham dan perkembangan positif yang sebelumnya disampaikan perusahaan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kondisi ini memicu reaksi yang dikenal sebagai <\/span><i><span style=\"font-weight: 400;\">sell the news<\/span><\/i><span style=\"font-weight: 400;\">, yaitu ketika investor menjual saham setelah informasi yang dinantikan akhirnya diumumkan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Selain itu, investor mulai mempertimbangkan apakah manfaat vaksin melanoma dapat diperluas ke jenis kanker lain untuk mendukung valuasi Moderna yang telah meningkat pesat.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dengan demikian, tekanan terhadap saham MRNA berkaitan dengan besarnya ekspektasi yang telah tercermin dalam harga saham serta prospek komersialisasi terapi tersebut.<\/span><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Investor_Menanti_Data_Lengkap_di_Konferensi_ESMO\"><\/span><b>Investor Menanti Data Lengkap di Konferensi ESMO<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Perhatian pasar berikutnya tertuju pada presentasi hasil lengkap uji klinis Moderna dan Merck dalam konferensi ESMO pada Sabtu, 24 Oktober 2026.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Informasi tambahan mengenai efektivitas terapi pada berbagai kelompok pasien, perkembangan data kelangsungan hidup, dan proses regulasi akan menjadi faktor penting untuk menilai prospek vaksin melanoma tersebut.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pergerakan saham Moderna juga menunjukkan bahwa respons pasar terhadap hasil penelitian dapat dipengaruhi oleh valuasi dan ekspektasi sebelumnya, meskipun data klinis menunjukkan perkembangan positif.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tekanan tersebut relatif terkonsentrasi pada Moderna. Pada perdagangan yang sama, saham perusahaan kesehatan lain seperti Eli Lilly, Johnson &amp; Johnson, dan Pfizer justru menguat, sementara ETF bioteknologi IBB dan XBI hanya mencatat pelemahan terbatas.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Bagi investor yang memantau Moderna (MRNA) dan Merck (MRK), perkembangan uji klinis berikutnya serta respons pasar setelah presentasi resmi menjadi informasi penting untuk dicermati.<\/span><\/p>\n<div style=\"background: linear-gradient(135deg,#19233F 0%,#292967 100%); border-radius: 20px; padding: 28px 24px; margin: 32px 0; box-sizing: border-box; text-align: left;\">\n<div style=\"display: inline-block; background: #303A59; border: 1px solid #56617D; border-radius: 999px; padding: 7px 14px; margin-bottom: 16px; color: #eaf0ff; font-size: 13px; font-weight: bold; line-height: 1.4;\">\ud83d\udcc8 Saham AS \u2022 Sektor Bioteknologi<\/div>\n<p style=\"margin: 0 0 12px; color: #ffffff; font-size: 22px; line-height: 1.35; font-weight: 800;\">Inovasi Berjalan, Sahamnya Bergerak. Pantau MRNA!<\/p>\n<p style=\"margin: 0 0 24px; color: #dce2f5; font-size: 15px; line-height: 1.7;\">Pantau pergerakan MRNA dan saham perusahaan kesehatan AS lainnya melalui Nanovest. Ikuti juga perkembangan pasar dan industri bioteknologi lewat News &amp; Artikel Tips.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 12px; align-items: center;\">\n<p><a style=\"display: inline-block; background: #7C3AED; color: #ffffff; text-decoration: none; font-size: 14px; font-weight: bold; padding: 12px 19px; border-radius: 9px; text-align: center; line-height: 1.5;\" href=\"https:\/\/www.nanovest.io\/\" target=\"_blank\" rel=\"noopener noreferrer\">Jelajahi Saham AS \u2192<br \/>\n<\/a><\/p>\n<p><a style=\"display: inline-block; background: #FFFFFF; color: #292967; text-decoration: none; font-size: 14px; font-weight: bold; padding: 12px 19px; border-radius: 9px; text-align: center; line-height: 1.5;\" href=\"https:\/\/www.nanovest.io\/blog\/\" target=\"_blank\" rel=\"noopener noreferrer\">News &amp; Artikel Tips \u2192<br \/>\n<\/a><\/p>\n<\/div>\n<p style=\"margin: 20px 0 0; color: #b8c2dd; font-size: 11px; line-height: 1.6;\">Investasi saham mengandung risiko, termasuk volatilitas harga dan potensi kehilangan modal. Pelajari fundamental perusahaan dan sesuaikan keputusan dengan profil risikomu.<span style=\"color: #333333; font-size: 14px;\">\u00a0<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Saham Moderna (MRNA) mengalami tekanan tajam pada perdagangan Kamis, 22 Oktober 2026, setelah hasil uji klinis tahap akhir vaksin kanker melanoma yang dikembangkan bersama Merck (MRK) beredar lebih awal dari jadwal. Saham Moderna sempat anjlok lebih dari 25% sebelum memangkas kerugian dan ditutup turun 17,57%. Penurunan tersebut terjadi meskipun data penelitian menunjukkan hasil positif. Kondisi<\/p>\n","protected":false},"author":35,"featured_media":28489,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80,39],"tags":[74,664,398,28,52,29],"class_list":["post-28488","post","type-post","status-publish","format-standard","has-post-thumbnail","category-berita","category-saham-as","tag-berita","tag-merck","tag-moderna","tag-saham-amerika","tag-saham-as","tag-us-stocks"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Maretha Putri\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"id_ID\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita\" \/>\n\t\t<meta property=\"og:description\" content=\"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-23T07:00:18+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-23T07:00:18+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nanovest\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@nanovest_io\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"name\":\"Berita\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"position\":2,\"name\":\"Berita\",\"item\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#listItem\",\"name\":\"Data Vaksin Kanker Bocor, Saham Moderna Turun\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#listItem\",\"position\":3,\"name\":\"Data Vaksin Kanker Bocor, Saham Moderna Turun\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/category\\\/berita\\\/#listItem\",\"name\":\"Berita\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#newsarticle\",\"name\":\"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita\",\"headline\":\"Data Vaksin Kanker Bocor, Saham Moderna Turun\",\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Moderna-Melanoma-Vaccine-Market-Plunge.webp\",\"width\":1672,\"height\":941,\"caption\":\"Ilustrasi hasil uji klinis vaksin kanker Moderna di laboratorium, dengan grafik penurunan saham MRNA sebesar 17,57%.\"},\"datePublished\":\"2026-10-23T14:00:18+07:00\",\"dateModified\":\"2026-10-23T14:00:18+07:00\",\"inLanguage\":\"id-ID\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#webpage\"},\"articleSection\":\"Berita\",\"dateline\":\"Published on Oktober 23, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\",\"name\":\"Nanovest\",\"description\":\"Nanovest is an Indonesian digital investment and asset trading platform operated by PT Tumbuh Bersama Nano.\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"email\":\"care@nanovest.io\",\"foundingDate\":\"2022-08-24\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":0,\"maxValue\":150},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/site-logo-color.png\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#organizationLogo\",\"width\":250,\"height\":250,\"caption\":\"site-logo-color\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nanovest\",\"https:\\\/\\\/twitter.com\\\/nanovest_io\",\"https:\\\/\\\/www.instagram.com\\\/nanovest.io\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC5Y5fD2FApTWMc0c2mlxzIg\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nano-vest\\\/\",\"https:\\\/\\\/www.threads.com\\\/@nanovest.io\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/\",\"name\":\"Maretha Putri\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png\",\"width\":96,\"height\":96,\"caption\":\"Maretha Putri\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#webpage\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/\",\"name\":\"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita\",\"description\":\"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.\",\"inLanguage\":\"id-ID\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/author\\\/maretha-putri\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Moderna-Melanoma-Vaccine-Market-Plunge.webp\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#mainImage\",\"width\":1672,\"height\":941,\"caption\":\"Ilustrasi hasil uji klinis vaksin kanker Moderna di laboratorium, dengan grafik penurunan saham MRNA sebesar 17,57%.\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/berita\\\/data-vaksin-kanker-bocor-moderna-turun-28488\\\/#mainImage\"},\"datePublished\":\"2026-10-23T14:00:18+07:00\",\"dateModified\":\"2026-10-23T14:00:18+07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.nanovest.io/blog\\\/\",\"name\":\"Nanovest\",\"alternateName\":\"Blog Nanovest\",\"description\":\"Artikel dan Berita Kripto, Saham AS, dan Emas\",\"inLanguage\":\"id-ID\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nanovest.io/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita<\/title>\n\n","aioseo_head_json":{"title":"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita","description":"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.","canonical_url":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/#listItem","position":1,"name":"Home","item":"https:\/\/www.nanovest.io/blog\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","name":"Berita"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","position":2,"name":"Berita","item":"https:\/\/www.nanovest.io/blog\/category\/berita\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#listItem","name":"Data Vaksin Kanker Bocor, Saham Moderna Turun"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#listItem","position":3,"name":"Data Vaksin Kanker Bocor, Saham Moderna Turun","previousItem":{"@type":"ListItem","@id":"https:\/\/www.nanovest.io/blog\/category\/berita\/#listItem","name":"Berita"}}]},{"@type":"NewsArticle","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#newsarticle","name":"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita","headline":"Data Vaksin Kanker Bocor, Saham Moderna Turun","author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author"},"publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp","width":1672,"height":941,"caption":"Ilustrasi hasil uji klinis vaksin kanker Moderna di laboratorium, dengan grafik penurunan saham MRNA sebesar 17,57%."},"datePublished":"2026-10-23T14:00:18+07:00","dateModified":"2026-10-23T14:00:18+07:00","inLanguage":"id-ID","mainEntityOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#webpage"},"isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#webpage"},"articleSection":"Berita","dateline":"Published on Oktober 23, 2026."},{"@type":"Organization","@id":"https:\/\/www.nanovest.io/blog\/#organization","name":"Nanovest","description":"Nanovest is an Indonesian digital investment and asset trading platform operated by PT Tumbuh Bersama Nano.","url":"https:\/\/www.nanovest.io/blog\/","email":"care@nanovest.io","foundingDate":"2022-08-24","numberOfEmployees":{"@type":"QuantitativeValue","minValue":0,"maxValue":150},"logo":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2023\/03\/site-logo-color.png","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#organizationLogo","width":250,"height":250,"caption":"site-logo-color"},"image":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/nanovest","https:\/\/twitter.com\/nanovest_io","https:\/\/www.instagram.com\/nanovest.io\/","https:\/\/www.youtube.com\/channel\/UC5Y5fD2FApTWMc0c2mlxzIg","https:\/\/www.linkedin.com\/company\/nano-vest\/","https:\/\/www.threads.com\/@nanovest.io"]},{"@type":"Person","@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author","url":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/","name":"Maretha Putri","image":{"@type":"ImageObject","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#authorImage","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/04\/cropped-ChatGPT-Image-Apr-6-2026-12_10_31-PM-96x96.png","width":96,"height":96,"caption":"Maretha Putri"}},{"@type":"WebPage","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#webpage","url":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/","name":"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita","description":"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.","inLanguage":"id-ID","isPartOf":{"@id":"https:\/\/www.nanovest.io/blog\/#website"},"breadcrumb":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#breadcrumblist"},"author":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author"},"creator":{"@id":"https:\/\/www.nanovest.io/blog\/author\/maretha-putri\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp","@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#mainImage","width":1672,"height":941,"caption":"Ilustrasi hasil uji klinis vaksin kanker Moderna di laboratorium, dengan grafik penurunan saham MRNA sebesar 17,57%."},"primaryImageOfPage":{"@id":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/#mainImage"},"datePublished":"2026-10-23T14:00:18+07:00","dateModified":"2026-10-23T14:00:18+07:00"},{"@type":"WebSite","@id":"https:\/\/www.nanovest.io/blog\/#website","url":"https:\/\/www.nanovest.io/blog\/","name":"Nanovest","alternateName":"Blog Nanovest","description":"Artikel dan Berita Kripto, Saham AS, dan Emas","inLanguage":"id-ID","publisher":{"@id":"https:\/\/www.nanovest.io/blog\/#organization"}}]},"og:locale":"id_ID","og:site_name":"Blog Nanovest - Artikel dan Berita Kripto, Saham AS, dan Emas","og:type":"article","og:title":"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita","og:description":"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.","og:url":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/","og:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp","og:image:secure_url":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp","og:image:width":1672,"og:image:height":941,"article:published_time":"2026-10-23T07:00:18+00:00","article:modified_time":"2026-10-23T07:00:18+00:00","article:publisher":"https:\/\/www.facebook.com\/nanovest","twitter:card":"summary_large_image","twitter:site":"@nanovest_io","twitter:title":"Data Vaksin Kanker Bocor, Saham Moderna Turun - Berita","twitter:description":"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.","twitter:creator":"@nanovest_io","twitter:image":"https:\/\/www.nanovest.io/blog\/wp-content\/uploads\/2026\/10\/Moderna-Melanoma-Vaccine-Market-Plunge.webp"},"aioseo_meta_data":{"post_id":"28488","title":"#post_title #separator_sa Berita","description":"Saham Moderna anjlok 17,57% setelah data vaksin kanker melanoma bocor. Simak hasil uji klinis bersama Merck dan alasan investor melepas saham MRNA.","keywords":null,"keyphrases":{"focus":{"keyphrase":"moderna","score":0,"analysis":[]},"additional":[{"keyphrase":"merck","score":0}]},"primary_term":{"category":80},"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":true,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-10-23 06:55:19","updated":"2026-10-23 07:00:18","focus_keyword":"moderna","additional_keywords":[{"word":"merck","score":89,"items":{"introductionKeyword":{"score":9},"keyphraseLength":{"score":9},"keyphraseDensity":{"score":9},"functionWordsInKeyphrase":{"score":9},"textCompetingLinks":{"score":9},"imageKeyphrase":{"score":3}}}],"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.nanovest.io/blog\/category\/berita\/\" title=\"Berita\">Berita<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\tData Vaksin Kanker Bocor, Saham Moderna Turun\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.nanovest.io/blog\/"},{"label":"Berita","link":"https:\/\/www.nanovest.io/blog\/category\/berita\/"},{"label":"Data Vaksin Kanker Bocor, Saham Moderna Turun","link":"https:\/\/www.nanovest.io/blog\/berita\/data-vaksin-kanker-bocor-moderna-turun-28488\/"}],"_links":{"self":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/28488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/comments?post=28488"}],"version-history":[{"count":1,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/28488\/revisions"}],"predecessor-version":[{"id":28490,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/posts\/28488\/revisions\/28490"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media\/28489"}],"wp:attachment":[{"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/media?parent=28488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/categories?post=28488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nanovest.io/blog\/wp-json\/wp\/v2\/tags?post=28488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}